Target intelligence / Profile preview

Influenza A virus H5N1 antigen

Molecular classification
Other (viral antigen), Protein (viral nucleoprotein, glycoprotein)
01

Overview

The term **Influenza A virus H5N1 antigen** is not a specific molecular target but rather refers collectively to antigenic proteins present on the Influenza A virus of subtype H5N1. Key antigens include **hemagglutinin (HA)**, **neuraminidase (NA)**, and **nucleoprotein (NP)**: - **Hemagglutinin (HA):** Mediates viral attachment and entry into host cells. It binds to host cell sialic acid receptors, facilitating membrane fusion and infection initiation. It is a primary target for neutralizing antibodies and vaccine development. - **Neuraminidase (NA):** An enzyme that facilitates the release of new viral particles by cleaving sialic acids from host cell glycoproteins, preventing aggregation and promoting viral spread. NA inhibitors (oseltamivir, zanamivir, peramivir) are clinically used antivirals targeting this activity[2]. - **Nucleoprotein (NP):** Binds the viral RNA genome, forming the ribonucleoprotein complex essential for viral replication and transcription; also a candidate for universal vaccine targets due to its high conservation[1]. **Influenza A virus H5N1 antigen** as a term is overly broad and not a single canonical target molecule. For clarity and specificity in research or drug development contexts, it is important to specify which antigen (e.g., H5N1 hemagglutinin, H5N1 neuraminidase, H5N1 nucleoprotein) is being referenced. This broad term is clinically relevant for **diagnostics** (presence of antigens in samples indicates infection) and **vaccine development** (antigens drive immune responses). However, mechanistic drug targeting and molecular classification require specifying the antigen or protein in question. **Note:** - Marked as *is_incorrect: true* because "Influenza A virus H5N1 antigen" is too unspecific for a single molecular target; the proper approach is to refer to individual well-defined proteins such as "Influenza A virus H5N1 hemagglutinin," "neuraminidase," or "nucleoprotein."[1][2]

Other names
Influenza A H5N1 proteinH5N1 antigenInfluenza A virus H5N1 nucleoprotein (for NP component)Influenza A virus H5N1 neuraminidase (for NA component)Influenza A virus H5N1 hemagglutinin (for HA component)
02

Mechanism of action

Inhibition of viral neuraminidase activity (for listed drugs)

03

Biological functions

Immune response stimulationViral genome encapsidation (for nucleoprotein)Viral entry/attachment (for hemagglutinin)Viral release from host cell (for neuraminidase)
04

Disease associations

Infection
05

Safety considerations

Antigenic variabilityviral resistance to antiviralspotential for pandemic outbreaks
06

Interacting drugs

Oseltamivir

2 more in the full profile.

07

Biomarkers

Influenza A H5N1 antigen (for infection diagnosis and as a vaccine antigen)

Beyond the preview

Go deeper on Influenza A virus H5N1 antigen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A virus H5N1 antigen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call